An Italian scientist and Nobel prize nominee, Vittorio Erspamer of the University of Rome was the first person to analyze Kambo in a laboratory.  

In 1986, he wrote that it contains a ‘fantastic chemical cocktail with potential medical applications, unequalled by any other amphibian’. The chemicals that he referred to were peptides - short chain amino acids that make up proteins in our body.  We are made of water, peptides, and protein. Currently there are over 70 Kambo patents lodged, mainly in the USA. While scientists have been able to isolate and synthesize some of the peptides in kambo, there is no substitute for the real thing.

Some of the peptides in kambo are neuropeptides, which means that they specifically affect the activity of the brain and body by communicating with neurons.  Insulin, oxytocin, and endorphins are examples of integral neuropeptides. Other peptides found in kambo are bioactive, composed of a specific chain of amino acids which perform a function that the body recognizes as beneficial. The body opens to kambo at a cellular level, allowing it to clean out deposits left in the cells by foreign substances with no stress to the cells. This combination of peptides is a unique key that unlocks the body, allowing kambo cross the blood-brain barrier rather than being filtered out by the body’s defense system. This makes kambo an extremely powerful way to reach and treat disease.  

the Peptides:

Kambo Peptides:

Kambo’s bioactive peptides have a large variety of beneficial functions within the body, acting as vasodilators, anti-inflammatories, antimicrobials, blood-pressure regulators, stimulators of the pituitary gland, and much more. As research over the decades uncovered a mass of benefits from these peptides, pharmaceutical companies began to show interest in developing synthetic versions of the compounds. However due to Kambo’s complexity, no derived pharmaceuticals have been produced or come to market.